This seems plausible as this would better reflect the pathological time course of AD in relation to cognitive alterations, as tau pathology onset occurs much closer to symptomatic onset than amyloid pathology (Braak and Braak, 1991; Jack et al., 2009). This evidence concerns the gene MAPT and Alzheimer disease.